Company attributes
B2X
Founder
Legal Name
Themis Bioscience GmbH
Phone Number
+4312367151
Full Address
Muthgasse 11/2, 1190 Vienna, Austria
Investors
Founded Date
September 2009
Total Funding Amount (USD)
68,000,000
Latest Funding Round Date
September 2019
Competitors
Business Model
Licensing
Commerce
Glassdoor ID
Acquisition Transaction
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Wikidata ID
Themis Bioscience is a Vienna-based company with a focus on utilizing technology that it has developed to advance vaccine candidates for various infectious diseases. The company states that its Themaxyn platform allows for researchers to rapidly identify and develop vaccines.
COVID-19
The company worked in collaboration with the Pasteur Institute during the COVID-19 pandemic. The role of Themis Bioscience was to provide scaling and manufacturing services once its partners had developed and tested a vaccine. The time frame for when the manufacturing will take place is unknown.
Timeline
No Timeline data yet.
